The present invention provides compounds able to induce neuroprotection of damaged neurons and boost the remyelination potential of oligodendrocytes. Said compounds have been identified through methods of pharmacological screening on a small molecule library consisting of known pharmacologically active compounds and approved drugs. The screening method is also included in the invention.

COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS

Olla S.;
2022

Abstract

The present invention provides compounds able to induce neuroprotection of damaged neurons and boost the remyelination potential of oligodendrocytes. Said compounds have been identified through methods of pharmacological screening on a small molecule library consisting of known pharmacologically active compounds and approved drugs. The screening method is also included in the invention.
2022
Istituto di Ricerca Genetica e Biomedica - IRGB
COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS
File in questo prodotto:
File Dimensione Formato  
PCTEP2022056085-appb-000002-en-20220309.pdf

accesso aperto

Descrizione: Patent
Tipologia: Altro materiale allegato
Licenza: Dominio pubblico
Dimensione 5.12 MB
Formato Adobe PDF
5.12 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/537322
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact